Latest News - NovaBay Pharmaceuticals

Monday, May 22, 2017 | Earnings & Financials, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Receives Noncompliance Notice from NYSE

NovaBay Pharmaceuticals announced receipt of a letter from NYSE MKT LLC on May 16, 2017, stating that it is not in compliance with the continued listing standards (requiring stockholders’ equity…

Read the full story

Monday, October 31, 2016 | Earnings & Financials, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Successfully Regains Compliance with NYSE Continued Listing Requirements

NovaBay Pharmaceuticals announced that it has regained compliance with the NYSE MKT continued listing standards. “Our NYSE listing is important as it creates a heightened profile for our stoc…

Read the full story

Friday, August 12, 2016 | Earnings & Financials, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Reports 2016 Second Quarter Financial Results

NovaBay Pharmaceuticals, a biopharmaceutical company focusing on commercializing its prescription Avenova lid and lash hygiene product for the domestic eye care market, reports financial results …

Read the full story

Wednesday, June 15, 2016 | Management/Leadership, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Appoints Mark M. Sieczkarek President and Chief Executive Officer

NovaBay Pharmaceuticals announced the appointment of Mark M. Sieczkarek as president and chief executive officer, effectively immediately. Mr. Sieczkarek has been a NovaBay director since January 2014…

Read the full story

Tuesday, May 03, 2016 | Clinical Trials, NovaBay Pharmaceuticals

Clinical Data Presented at ARVO Showing NovaBay’s Avenova Reduces Bacteria on Ocular Skin Surface by More than 90%

NovaBay Pharmaceuticals announced the presentation of clinical data demonstrating that Avenova reduced the bacterial load on the ocular skin surface by more than 90% in 20 minutes without affecting th…

Read the full story

Thursday, April 07, 2016 | Earnings & Financials, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Announces Agreement for Nearly $12 Million in Two-Tranche Private Placement

NovaBay Pharmaceuticals, a biopharmaceutical company focusing on commercializing its Avenova Lid and Lash Cleanser for the domestic eye care market, announces that it has entered into a securities pur…

Read the full story

Friday, November 20, 2015 | Management/Leadership, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Announces Restructuring to Focus on Avenova Commercialization

NovaBay Pharmaceuticals announced a corporate restructuring to focus on the commercialization of its prescription Avenova Lid and Lash Cleanser. NovaBay is also taking steps to reduce operating expens…

Read the full story

Thursday, September 24, 2015 | Partnerships, NovaBay Pharmaceuticals

NovaBay Announces Partnership with Alphaeon to Bring Avenova to Ophthalmologists and Their Patients Across the US

Alphaeon and NovaBay Pharmaceuticals announced that they have formed a partnership that will add NovaBay’s Avenova to the products that Alphaeon makes available to patients and doctors, accordin…

Read the full story

Thursday, June 04, 2015 | FDA Approval/Clearance, Product Releases, NovaBay Pharmaceuticals

FDA Clears NovaBay Pharmaceuticals' intelli-Case for Safely Disinfecting Contact Lenses with Hydrogen Peroxide

NovaBay Pharmaceuticals announced receipt of 510(k) clearance from the FDA to market its novel intelli-Case with hydrogen peroxide solutions, according to a company news release. More than 24 milli…

Read the full story

Thursday, May 07, 2015 | Medical Studies, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals: Avenova Brings Significant Improvement to Patients With Blepharitis

Family Eye Care Optometry and NovaBay Pharmaceuticals announced that Guru Sharma OD, PhD, Optometrist at Family Eye Care Optometry and Assistant Professor at Western University of the Health Sciences&…

Read the full story

Monday, March 09, 2015 | Product Releases, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Signs Avenova and NeutroPhase Distribution Agreements

NovaBay Pharmaceuticals announced that it has signed two new distribution agreements to market its products in international markets, according to a company news release. Sarmedic will have exclusive …

Read the full story